Roche said the test strips are expired or nearly expired products that are repackaged with counterfeit labels bearing Roche's ...
3mon
GlobalData on MSNRoche’s Alzheimer’s test shows high negative predictive valueRoche was quick to note that the test’s performance was “only minimally impacted” by the patients’ age, sex, body mass index ...
The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.
Roche has introduced the first test based on a new technology – called TAGS – that it believes could revolutionise testing for infectious diseases by allowing high-throughput detection to be ...
Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...
Roche Tissue Diagnostics also collaborates with dozens of pharmaceutical companies to test and develop better tools for evaluating cancer treatments. It doesn't engage in animal testing or conduct ...
Roche has obtained U.S. government green lights ... influenza B and strep throat, as well as an in-lab test for Clostridium difficile, or C. diff.
1 The Roche Diagnostics Tina-quant® Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein (a) in a person's bloodstream (serum and plasma), and will be broadly available ...
Roche stopped studying cibisatamab in combination with its checkpoint inhibitor Tecentriq in colorectal cancer patients last year but continued to test the asset with its 4-1BBxFAP bispecific.
Roche Diagnostics is cutting an unspecified number of jobs at two locations in Central Indiana as it struggles to cope with changing conditions in the diabetes care market. Company spokesman Todd ...
Metropolis Healthcare and Roche Diagnostics India introduce self-sampling HPV DNA test for cervical cancer screening at home.
After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results